Global Apomorphine Hydrochloride 麻豆原创 Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030

Publication ID:

PB506246821

Publication Date:

June 18, 2024

Pages:

133

Publisher:

MRRPB5

Countries:

Global [1]

USD 5,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and 伪-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.
The global Apomorphine Hydrochloride market is projected to reach US$ 364.1 million by 2030 from an estimated US$ 289.5 million in 2024, at a CAGR of 3.9% during 2024 and 2030.
The classification of Apomorphine Hydrochloride includes Injection, Tablets, Thinfilm, etc and the proportion of Injection in 2019 is about 89.88%, and the proportion is in decreasing trend from 2020 to 2025.
Apomorphine Hydrochloride is widely used through Parkinson Disease and Erectile Dysfunction. The most proportion of Apomorphine Hydrochloride is used for Parkinson Disease, and the sales proportion in 2019 is 89.88%.
Europe is the largest consumption place, with a consumption market share nearly 54.19% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of 23.69%.
麻豆原创 competition is not intense. Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Apomorphine Hydrochloride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Apomorphine Hydrochloride.
The Apomorphine Hydrochloride market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Apomorphine Hydrochloride market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Apomorphine Hydrochloride manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
麻豆原创 Segmentation
By Company
Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
Ever Pharma
Evolan Pharma AB (PharmSwed)
Tianjin Tianwei Pharmaceutical
Sunovion
Segment by Type
Injection
Tablets
Thinfilm
Nasal Powder (Pipeline)
Segment by Application
Parkinson Disease
Erectile Dysfunction
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Apomorphine Hydrochloride in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Apomorphine Hydrochloride manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Apomorphine Hydrochloride sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Study Coverage
1.1 Apomorphine Hydrochloride Product Introduction
1.2 麻豆原创 by Type
1.2.1 Global Apomorphine Hydrochloride 麻豆原创 Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Injection
1.2.3 Tablets
1.2.4 Thinfilm
1.2.5 Nasal Powder (Pipeline)
1.3 麻豆原创 by Application
1.3.1 Global Apomorphine Hydrochloride 麻豆原创 Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Parkinson Disease
1.3.3 Erectile Dysfunction
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Apomorphine Hydrochloride 麻豆原创 Size Estimates and Forecasts
2.1.1 Global Apomorphine Hydrochloride Revenue 2019-2030
2.1.2 Global Apomorphine Hydrochloride Sales 2019-2030
2.2 Apomorphine Hydrochloride 麻豆原创 Size by Region: 2023 Versus 2030
2.3 Apomorphine Hydrochloride Sales by Region (2019-2030)
2.3.1 Global Apomorphine Hydrochloride Sales by Region: 2019-2024
2.3.2 Global Apomorphine Hydrochloride Sales Forecast by Region (2025-2030)
2.3.3 Global Apomorphine Hydrochloride Sales 麻豆原创 Share by Region (2019-2030)
2.4 Apomorphine Hydrochloride 麻豆原创 Estimates and Projections by Region (2025-2030)
2.4.1 Global Apomorphine Hydrochloride Revenue by Region: 2019-2024
2.4.2 Global Apomorphine Hydrochloride Revenue Forecast by Region (2025-2030)
2.4.3 Global Apomorphine Hydrochloride Revenue 麻豆原创 Share by Region (2019-2030)
3 Global Apomorphine Hydrochloride by Manufacturers
3.1 Global Top Apomorphine Hydrochloride Manufacturers by Sales
3.1.1 Global Apomorphine Hydrochloride Sales by Manufacturer (2019-2024)
3.1.2 Global Apomorphine Hydrochloride Sales 麻豆原创 Share by Manufacturer (2019-2024)
3.2 Global Top Apomorphine Hydrochloride Manufacturers by Revenue
3.2.1 Global Apomorphine Hydrochloride Revenue by Manufacturer (2019-2024)
3.2.2 Global Apomorphine Hydrochloride Revenue Share by Manufacturer (2019-2024)
3.3 Global Apomorphine Hydrochloride Price by Manufacturer (2019-2024)
3.4 Competitive Landscape
3.4.1 Key Apomorphine Hydrochloride Manufacturers Covered: Ranking by Revenue
3.4.2 Global Apomorphine Hydrochloride 麻豆原创 Concentration Ratio (CR5 and HHI) & (2019-2024)
3.4.3 Global Apomorphine Hydrochloride 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Apomorphine Hydrochloride Manufacturing Base Distribution, Product Type
3.5.1 Apomorphine Hydrochloride Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Apomorphine Hydrochloride Product Type
3.5.3 Date of International Manufacturers Enter into Apomorphine Hydrochloride 麻豆原创
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Supernus Pharmaceuticals
4.1.1 Supernus Pharmaceuticals Company Information
4.1.2 Supernus Pharmaceuticals Description, Business Overview
4.1.3 Supernus Pharmaceuticals Apomorphine Hydrochloride Products Offered
4.1.4 Supernus Pharmaceuticals Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
4.1.5 Supernus Pharmaceuticals Apomorphine Hydrochloride Sales by Product in 2023
4.1.6 Supernus Pharmaceuticals Apomorphine Hydrochloride Sales by Application in 2023
4.1.7 Supernus Pharmaceuticals Apomorphine Hydrochloride Sales by Geographic Area in 2023
4.1.8 Supernus Pharmaceuticals Recent Developments
4.2 Britannia Pharmaceuticals STADA
4.2.1 Britannia Pharmaceuticals STADA Company Information
4.2.2 Britannia Pharmaceuticals STADA Description, Business Overview
4.2.3 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Products Offered
4.2.4 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
4.2.5 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Sales by Product in 2023
4.2.6 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Sales by Application in 2023
4.2.7 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Sales by Geographic Area in 2023
4.2.8 Britannia Pharmaceuticals STADA Recent Developments
4.3 Ever Pharma
4.3.1 Ever Pharma Company Information
4.3.2 Ever Pharma Description, Business Overview
4.3.3 Ever Pharma Apomorphine Hydrochloride Products Offered
4.3.4 Ever Pharma Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
4.3.5 Ever Pharma Apomorphine Hydrochloride Sales by Product in 2023
4.3.6 Ever Pharma Apomorphine Hydrochloride Sales by Application in 2023
4.3.7 Ever Pharma Apomorphine Hydrochloride Sales by Geographic Area in 2023
4.3.8 Ever Pharma Recent Developments
4.4 Evolan Pharma AB (PharmSwed)
4.4.1 Evolan Pharma AB (PharmSwed) Company Information
4.4.2 Evolan Pharma AB (PharmSwed) Description, Business Overview
4.4.3 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Products Offered
4.4.4 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
4.4.5 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Sales by Product in 2023
4.4.6 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Sales by Application in 2023
4.4.7 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Sales by Geographic Area in 2023
4.4.8 Evolan Pharma AB (PharmSwed) Recent Developments
4.5 Tianjin Tianwei Pharmaceutical
4.5.1 Tianjin Tianwei Pharmaceutical Company Information
4.5.2 Tianjin Tianwei Pharmaceutical Description, Business Overview
4.5.3 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Products Offered
4.5.4 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
4.5.5 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Sales by Product in 2023
4.5.6 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Sales by Application in 2023
4.5.7 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Sales by Geographic Area in 2023
4.5.8 Tianjin Tianwei Pharmaceutical Recent Developments
4.6 Sunovion
4.6.1 Sunovion Company Information
4.6.2 Sunovion Description, Business Overview
4.6.3 Sunovion Apomorphine Hydrochloride Products Offered
4.6.4 Sunovion Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
4.6.5 Sunovion Apomorphine Hydrochloride Sales by Product in 2023
4.6.6 Sunovion Apomorphine Hydrochloride Sales by Application in 2023
4.6.7 Sunovion Apomorphine Hydrochloride Sales by Geographic Area in 2023
4.6.8 Sunovion Recent Development
5 Breakdown Data by Type
5.1 Global Apomorphine Hydrochloride Sales by Type (2019-2030)
5.1.1 Global Apomorphine Hydrochloride Sales by Type (2019-2024)
5.1.2 Global Apomorphine Hydrochloride Sales Forecast by Type (2025-2030)
5.1.3 Global Apomorphine Hydrochloride Sales 麻豆原创 Share by Type (2019-2030)
5.2 Global Apomorphine Hydrochloride Revenue Forecast by Type (2019-2030)
5.2.1 Global Apomorphine Hydrochloride Revenue by Type (2019-2024)
5.2.2 Global Apomorphine Hydrochloride Revenue Forecast by Type (2025-2030)
5.2.3 Global Apomorphine Hydrochloride Revenue 麻豆原创 Share by Type (2019-2030)
5.3 Apomorphine Hydrochloride Average Selling Price (ASP) by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Apomorphine Hydrochloride Sales by Application (2019-2030)
6.1.1 Global Apomorphine Hydrochloride Sales by Application (2019-2024)
6.1.2 Global Apomorphine Hydrochloride Sales Forecast by Application (2025-2030)
6.1.3 Global Apomorphine Hydrochloride Sales 麻豆原创 Share by Application (2019-2030)
6.2 Global Apomorphine Hydrochloride Revenue Forecast by Application (2019-2030)
6.2.1 Global Apomorphine Hydrochloride Revenue by Application (2019-2024)
6.2.2 Global Apomorphine Hydrochloride Revenue Forecast by Application (2025-2030)
6.2.3 Global Apomorphine Hydrochloride Revenue 麻豆原创 Share by Application (2019-2030)
6.3 Apomorphine Hydrochloride Average Selling Price (ASP) by Application (2019-2030)
7 North America
7.1 North America Apomorphine Hydrochloride 麻豆原创 Size YoY Growth 2019-2030
7.2 North America Apomorphine Hydrochloride 麻豆原创 Facts & Figures by Country
7.2.1 North America Apomorphine Hydrochloride Sales by Country (2019-2030)
7.2.2 North America Apomorphine Hydrochloride Revenue by Country (2019-2030)
7.3 North America Apomorphine Hydrochloride Sales by Type (2019-2024)
7.4 North America Apomorphine Hydrochloride Sales by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Apomorphine Hydrochloride 麻豆原创 Size YoY Growth 2019-2030
8.2 Asia-Pacific Apomorphine Hydrochloride 麻豆原创 Facts & Figures by Region
8.2.1 Asia-Pacific Apomorphine Hydrochloride Sales by Region (2019-2030)
8.2.2 Asia-Pacific Apomorphine Hydrochloride Revenue by Region (2019-2030)
8.3 Asia-Pacific Apomorphine Hydrochloride Sales by Type (2019-2024)
8.4 Asia-Pacific Apomorphine Hydrochloride Sales by Application (2019-2024)
9 Europe
9.1 Europe Apomorphine Hydrochloride 麻豆原创 Size YoY Growth 2019-2030
9.2 Europe Apomorphine Hydrochloride 麻豆原创 Facts & Figures by Country
9.2.1 Europe Apomorphine Hydrochloride Sales by Country (2019-2030)
9.2.2 Europe Apomorphine Hydrochloride Revenue by Country (2019-2030)
9.3 Europe Apomorphine Hydrochloride Sales by Type (2019-2024)
9.4 Europe Apomorphine Hydrochloride Sales by Application (2019-2024)
10 Latin America
10.1 Latin America Apomorphine Hydrochloride 麻豆原创 Size YoY Growth 2019-2030
10.2 Latin America Apomorphine Hydrochloride 麻豆原创 Facts & Figures by Country
10.2.1 Latin America Apomorphine Hydrochloride Sales by Country (2019-2030)
10.2.2 Latin America Apomorphine Hydrochloride Revenue by Country (2019-2030)
10.3 Latin America Apomorphine Hydrochloride Sales by Type (2019-2024)
10.4 Latin America Apomorphine Hydrochloride Sales by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Apomorphine Hydrochloride 麻豆原创 Size YoY Growth 2019-2030
11.2 Middle East and Africa Apomorphine Hydrochloride 麻豆原创 Facts & Figures by Country
11.2.1 Middle East and Africa Apomorphine Hydrochloride Sales by Country (2019-2030)
11.2.2 Middle East and Africa Apomorphine Hydrochloride Revenue by Country (2019-2030)
11.3 Middle East and Africa Apomorphine Hydrochloride Sales by Type (2019-2024)
11.4 Middle East and Africa Apomorphine Hydrochloride Sales by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Apomorphine Hydrochloride Supply Chain Analysis
12.2 Apomorphine Hydrochloride Key Raw Materials and Upstream Suppliers
12.3 Apomorphine Hydrochloride Clients Analysis
12.4 Apomorphine Hydrochloride Sales Channel and Sales Model Analysis
12.4.1 Apomorphine Hydrochloride Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Apomorphine Hydrochloride Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Apomorphine Hydrochloride Distributors
13 麻豆原创 Dynamics
13.1 Apomorphine Hydrochloride Industry Trends
13.2 Apomorphine Hydrochloride 麻豆原创 Drivers
13.3 Apomorphine Hydrochloride 麻豆原创 Challenges
13.4 Apomorphine Hydrochloride 麻豆原创 Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

Companies Mentioned:

Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
Ever Pharma
Evolan Pharma AB (PharmSwed)
Tianjin Tianwei Pharmaceutical
Sunovion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.